Skip to main content
. 2022 Jul 13;14(7):1460. doi: 10.3390/pharmaceutics14071460

Figure 2.

Figure 2

Tumor growth curves of (A) CT26 and (B) MC38 tumor-bearing mice after administration of the different therapeutic groups. Checkpoint inhibitors were given days 3, 6 and 9 after tumor implantation and 90Y-GZP was given on day 12 (indicated by arrows). High dose of 90Y-GZP (22.2 MBq) after ICI achieved complete tumor response in both tumor models. * Statistically significant compared to all other groups (p < 0.05).